[Effects of vitamin D supplementation in early pregnancy on high-risk groups of gestational diabetes mellitus].

What Was Tested

The paper reports a study of Vitamin D, K2, Magnesium and Zinc, published as a randomized controlled trial.

To investigate the effect of vitamin D supplementation(VD) in early pregnancy on the serum 25-hydroxyvitamin D(25-OH-D) level and the risk of gestational diabetes mellitus(GDM).

Who Took Part

The abstract describes 101 women taking part.

PubMed indexes the participants as children, women only.

From October to December 2017, a total of 101 pregnant women with high risk factors for GDM were enrolled in the first pregnancy consultation at the nutrition clinic of Haidian Maternal and Child Health Hospital, and were randomly divided into intervention group and control group.

How the Study Was Run

The design is described as randomized.

Because people in this Vitamin D, K2, Magnesium and Zinc study were split into groups at random, differences between the groups are less likely to reflect who happened to join each one.

What Was Measured

PubMed files the paper under topics including Diabetes, Gestational, Dietary Supplements, Nutritional Status, Outcome Assessment, Health Care, Pregnancy Trimesters, Pregnant People and Vitamin D.

Author keywords: early pregnancy, gestational diabetes mellitus, health effect and nutritional intervention.

What This Means in Plain Language

The paper is a randomized study of Vitamin D, K2, Magnesium and Zinc in 101 women.

Its findings take up roughly 5 sentences of the abstract and are left out here on purpose; the source paper is the place to read them.

The publication is from 2019 (Wei sheng yan jiu = Journal of hygiene research), a journal based in China.

More context: the Vitamin D, K2, Magnesium and Zinc compound page, all human trials.